< Back to previous page
Researcher
Kathleen Claes
- Keywords:inherited predisposition for cancer
- Disciplines:Immunogenetics, Clinical genetics and molecular diagnostics, Epigenetics, Genetics, Cancer prevention, Cancer diagnosis, Oncology not elsewhere classified, Molecular diagnostics
Affiliations
- Department of Biomolecular Medicine (Department)
Member
From1 Oct 2018 → Today - Department of Pediatrics and medical genetics (Department)
Member
From1 Mar 1997 → 30 Sep 2018
Projects
1 - 10 of 24
- A versatile microscope for the imaging of living and fixed biological samplesFrom1 Dec 2025 → TodayFunding: BOF - scientific equipment program
- Joint Action on Networks of Expertise on CancerFrom1 Nov 2024 → TodayFunding: Other EU initiatives out of framework
- ThirdGenT: linking third-generation sequencing of (epi)genomes, (epi)transcriptomes and translatomes to life sciences revolutionizes oncology, rare diseases, microbiology, cell and gene technology, developmental and computational biologyFrom1 May 2024 → TodayFunding: FWO Medium Size Research Infrastructure
- Cancer predispositionFrom1 Jan 2024 → 31 Dec 2024Funding: BOF - projects
- Multi-omics approach to identify pancreatic cancer biomarkers in liquid biopsies of advanced stage patients by pioneering single cell mass spectrometry of CTCs and (epi)genetics characterization of cfDNAFrom1 Oct 2023 → TodayFunding: BOF - projects
- Joint Action on Networks of ExpertiseFrom1 Oct 2022 → 30 Sep 2024Funding: Other EU initiatives out of framework
- Cofunding core facility - UGent NGS CoreFrom1 Jul 2022 → TodayFunding: BOF - research organisations
- In vivo functional evaluation of unclassified variants, found in the breast cancer gene BRCA2, using CRISPR-mediated genome editing in zebrafishFrom15 Nov 2021 → TodayFunding: BOF - doctoral mandates
- Diagnosing HEreditary predisposition syndromes for Childhood cancer: Implementation in clinical PRactice (DHECIPR)From1 Jan 2021 → 31 Dec 2024Funding: FWO Applied Biomedical Research (TBM)
- CONDITIONAL: COvid-19: iNterplay between genetic preDisposITION and immunologicAl LandscapeFrom15 Apr 2020 → 14 Apr 2021Funding: BOF - projects
Publications
1 - 10 of 183
- Generation of two iPSC lines (UGENTi003 and UGENTi004) from patients with intermediate rod-cone dystrophy carrying the c.[-123C>T;701G>A]; [806_810del] variants in the RDH12 gene(2025)Published in: STEM CELL RESEARCHISSN: 1876-7753Volume: 86
- Replication stress, microcephalic primordial dwarfism, and compromised immunity in ATRIP deficient patients(2025)Published in: JOURNAL OF EXPERIMENTAL MEDICINEISSN: 1540-9538Issue: 5Volume: 222
- Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe) : a multicenter prospective trial-trial protocol(2025)Published in: BMC SURGERYISSN: 1471-2482Issue: 1Volume: 25
- Investigating chromosomal radiosensitivity in inborn errors of immunity : insights from DNA repair disorders and beyond(2025)Published in: JOURNAL OF CLINICAL IMMUNOLOGYISSN: 1573-2592Issue: 1Volume: 45
- Prime editing outperforms optimized homology-directed repair as a tool for knock-in generation in zebrafish(2024)Number of pages: 1
- Gebruik van farmacogenetische tests in België(2024)
- In memory of Ludwine Messiaen, Ph.D. (1956-2024)(2024)Volume: 106Pages: 535 - 536
- The clinical use of exome sequencing to diagnose PCD patients(2024)Volume: 32Pages: 385 - 385
- Identification of potentially actionable genetic variants in epithelial ovarian cancer : a retrospective cohort study(2024)Published in: NPJ PRECISION ONCOLOGYISSN: 2397-768XIssue: 1Volume: 8
- EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer(2024)Published in: EUROPEAN JOURNAL OF HUMAN GENETICSISSN: 1476-5438Volume: 32Pages: 479 - 488